United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
478.16
-6.90 (-1.42%)
At close: Mar 6, 2026, 4:00 PM EST
477.00
-1.16 (-0.24%)
After-hours: Mar 6, 2026, 7:51 PM EST
United Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
$524.62
Upside
+9.72%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $655 → $705 | Strong Buy | Maintains | $655 → $705 | +47.44% | Mar 5, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $525 → $600 | Strong Buy | Maintains | $525 → $600 | +25.48% | Feb 26, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $525 → $575 | Strong Buy | Maintains | $525 → $575 | +20.25% | Feb 26, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $575 → $600 | Buy | Maintains | $575 → $600 | +25.48% | Feb 26, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $587 → $643 | Buy | Maintains | $587 → $643 | +34.47% | Feb 26, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $423 → $466 | Hold | Maintains | $423 → $466 | -2.54% | Feb 26, 2026 |
| UBS | UBS | Strong Buy Maintains $600 → $645 | Strong Buy | Maintains | $600 → $645 | +34.89% | Jan 6, 2026 |
| UBS | UBS | Strong Buy Maintains $580 → $600 | Strong Buy | Maintains | $580 → $600 | +25.48% | Nov 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $500 → $525 | Strong Buy | Maintains | $500 → $525 | +9.80% | Oct 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $569 → $587 | Buy | Maintains | $569 → $587 | +22.76% | Oct 30, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $414 → $423 | Hold | Maintains | $414 → $423 | -11.54% | Oct 30, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $328 → $435 | Hold | Maintains | $328 → $435 | -9.03% | Oct 10, 2025 |
| UBS | UBS | Strong Buy Maintains $560 → $580 | Strong Buy | Maintains | $560 → $580 | +21.30% | Sep 29, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $569 | Buy | Initiates | $569 | +19.00% | Sep 26, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $405 → $525 | Buy | Maintains | $405 → $525 | +9.80% | Sep 10, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $510 → $575 | Buy | Maintains | $510 → $575 | +20.25% | Sep 5, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.